These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30551391)

  • 1. MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.
    Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
    Biomed Pharmacother; 2019 Jan; 109():1406-1410. PubMed ID: 30551391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
    Xu S; Ge J; Zhang Z; Zhou W
    Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells].
    Zhang Y; Hao T; Zhang H; Wei P; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):247-252. PubMed ID: 29773107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway.
    Gao S; Zhao Z; Wu R; Wu L; Tian X; Zhang Z
    Aging (Albany NY); 2018 Aug; 10(8):2113-2121. PubMed ID: 30153654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J; Lv J; Chen J; Zhang X; Ji Y
    Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling.
    Liu Y; Xu L; Lu B; Zhao M; Li L; Sun W; Qiu Z; Zhang B
    Mol Immunol; 2019 Dec; 116():18-28. PubMed ID: 31574452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer.
    Xie F; Huang Q; Liu CH; Lin XS; Liu Z; Liu LL; Huang DW; Zhou HC
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):678-686. PubMed ID: 29461595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway.
    Liao Y; Yin X; Deng Y; Peng X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways.
    Gu Z; You Z; Yang Y; Ding R; Wang M; Pu J; Chen J
    Bioengineered; 2021 Dec; 12(1):4719-4735. PubMed ID: 34338146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.
    Li JZ; Wang ZL; Xu WH; Li Q; Gao L; Wang ZM
    Cancer Invest; 2016; 34(4):181-8. PubMed ID: 27031291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
    Lu R; Yang Z; Xu G; Yu S
    Biomed Pharmacother; 2018 Sep; 105():633-644. PubMed ID: 29898430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
    Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
    Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
    Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
    Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
    Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skullcapflavone I suppresses proliferation of human lung cancer cells via down-regulating microRNA-21.
    Yang Y; An R; Feng T; Qin X; Zhang J; Bo Y; Niu B
    Exp Mol Pathol; 2019 Oct; 110():104285. PubMed ID: 31301304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9.
    Sheng W; Xu W; Ding J; Li L; You X; Wu Y; He Q
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34590156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis of human prostate cancer cells induced by marine actinomycin X2 through the mTOR pathway compounded by MiRNA144.
    Liu J; Xie S; Wu Y; Xu M; Ao C; Wang W; Zeng Q; Hu W; Li M
    Anticancer Drugs; 2016 Mar; 27(3):156-63. PubMed ID: 26645890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.